肝細胞癌のランダム化対照試験におけるプラセボの反応率,生存状況および有害事象:メタ解析
Wei-Yu Chen1,2, Qing Chen2,3, Chen-Chen Wang2,4
1Department of Integrative Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen 361000, Fujian Province, China.
World journal of hepatology
|September 3, 2025
まとめ
進行した肝細胞癌 (HCC) の患者の3分の1以上は,治療なしで病気のコントロールを示しています. このメタ解析は,プラセボアームの有害事象を強調し,将来の臨床試験の設計とがん治療に対する患者の期待を伝える.
科学分野:
- 腫瘍学
- 臨床試験
- メタ解析
背景:
- 肝細胞癌 (HCC) のランダム化対照試験 (RCT) は,しばしばプラセボアームを無視している.
- この研究は,HCCRCにおけるプラセボアームのデータを分析することに焦点を当てています.
研究 の 目的:
- HCC RCT のプラセボアームにおける応答率,生存状態,および有害事象を体系的に評価する.
- より効果的な単腕試験を設計し,患者の期待を管理するための洞察を提供すること.
主な方法:
- 2023年12月31日までの主要データベース (PubMed,Embase,Cochrane Library) で体系的な文献検索が行われました.
- 2390人の患者を対象とした18件のRCTのデータをメタ解析に含めた.
- 統計分析はRソフトウェアを用いて行われました.
主要な成果:
- プラセボ群の総合疾患制御率は38%で,客観的な応答率は1%であった.
- 平均全生存期と進行性生存期はそれぞれ7. 9ヶ月と1. 9ヶ月でした.
- 3度目または4度目の有害事象は,患者の37%で発生し,治療中断/ 減少は20%で,治療中止は9%であった.
結論:
- 進行したHCC患者の有意な割合は,治療なしで病気のコントロールを達成します.
- 試験設計と患者カウンセリングにおいて慎重に考慮する必要がある.
- 発見は単一アーム試験の設計を支持し,がん治療の患者の理解を高める.
さらに関連する動画
関連する概念動画
01:12Hazard Ratio
241
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
241
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:20Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280